{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:31Z","timestamp":1792162171661,"version":"4.4.0"},"reference-count":63,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI168337"],"award-info":[{"award-number":["R01AI168337"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vaccine development often involves modifying native viral proteins to enhance their stability and antigenicity, as seen in approved Covid-19 vaccines and multiple HIV vaccine candidates currently under investigation. High throughput screening on the surface of mammalian cells enables the rapid evaluation of oligomeric, glycosylated viral proteins and the identification of mutations that improve their properties for vaccine design. Here, we developed an experimental platform that uses the PiggyBac transposon system to display libraries of viral protein variants on the surface of mammalian cells for efficient screening. This approach addresses common challenges in existing mammalian display systems, including low transfection efficiency and the need to develop stable cell lines for iterative selection rounds. The new platform was validated by displaying diverse viral proteins and screening influenza hemagglutinin libraries to identify mutations that increased binding of broadly cross-reactive antibodies to a conserved but partially occluded epitope of interest for the development of a universal influenza vaccine. These results demonstrate the potential of this mammalian display platform to rapidly engineer immunogens with desired antigenic properties for vaccine design.<\/jats:p>","DOI":"10.1021\/acssynbio.6c00027","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:01:35Z","timestamp":1791349295000},"page":"3993-4006","source":"Crossref","is-referenced-by-count":0,"title":["A Mammalian Surface Display Platform to Optimize the Antigenicity of Viral Proteins"],"prefix":"10.1021","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0465-3503","authenticated-orcid":true,"given":"Jayani","family":"Christopher","sequence":"first","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-1662","authenticated-orcid":true,"given":"Caitlin","family":"Harris","sequence":"additional","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Marston","sequence":"additional","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie","family":"Frazier","sequence":"additional","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai L.","family":"Azoitei","sequence":"additional","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]},{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27710"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"9","key":"2026101610065332700_cit1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"issue":"2","key":"2026101610065332700_cit2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1128\/jvi.74.2.627-643.2000","article-title":"A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure","volume":"74","author":"Binley","year":"2000","journal-title":"J. Virol."},{"issue":"17","key":"2026101610065332700_cit3","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1016\/j.cell.2021.06.029","article-title":"Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses","volume":"184","author":"Nathan","year":"2021","journal-title":"Cell"},{"issue":"10","key":"2026101610065332700_cit4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41594-020-0483-8","article-title":"Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation","volume":"27","author":"McCallum","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"2026101610065332700_cit5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.coviro.2013.05.010","article-title":"Advances in structure-based vaccine design","volume":"3","author":"Kulp","year":"2013","journal-title":"Curr. Opin. Virol."},{"issue":"S7","key":"2026101610065332700_cit6","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25797","article-title":"Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review","volume":"24","author":"Derking","year":"2021","journal-title":"J. Int. AIDS Soc."},{"issue":"6483","key":"2026101610065332700_cit7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"1","key":"2026101610065332700_cit8","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01673-22","article-title":"Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and Yield","volume":"97","author":"Wrapp","year":"2023","journal-title":"J. Virol."},{"issue":"6470","key":"2026101610065332700_cit9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay7199","article-title":"Targeted selection of HIV-specific antibody mutations by engineering B cell maturation","volume":"366","author":"Saunders","year":"2019","journal-title":"Science"},{"issue":"7","key":"2026101610065332700_cit10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nsmb.3051","article-title":"Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env","volume":"22","author":"Do Kwon","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7523","key":"2026101610065332700_cit11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"issue":"7","key":"2026101610065332700_cit12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1080\/19420862.2017.1364824","article-title":"Mammalian cell surface display for monoclonal antibody-based FACS selection of viral envelope proteins","volume":"9","author":"Bruun","year":"2017","journal-title":"mAbs"},{"issue":"17","key":"2026101610065332700_cit13","doi-asserted-by":"publisher","first-page":"10157","DOI":"10.1128\/JVI.01494-14","article-title":"High-throughput identification of loss-of-function mutations for anti-interferon activity in the influenza A virus NS segment","volume":"88","author":"Wu","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"2026101610065332700_cit14","doi-asserted-by":"publisher","first-page":"14455","DOI":"10.1038\/s41598-017-14823-w","article-title":"High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"issue":"5\u22126","key":"2026101610065332700_cit15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1515\/hsz-2020-0377","article-title":"Antibody display technologies: selecting the cream of the crop","volume":"403","author":"Valldorf","year":"2022","journal-title":"Biol Chem"},{"issue":"12","key":"2026101610065332700_cit16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.tibtech.2021.03.003","article-title":"Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery","volume":"39","author":"Laustsen","year":"2021","journal-title":"Trends Biotechnol."},{"issue":"10","key":"2026101610065332700_cit17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164296","article-title":"Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning","volume":"11","author":"Gaiotto","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"2026101610065332700_cit18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"issue":"11","key":"2026101610065332700_cit19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00219-19","article-title":"Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States","volume":"93","author":"Heredia","year":"2019","journal-title":"J. Virol."},{"issue":"6280","key":"2026101610065332700_cit20","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen","volume":"351","author":"Jardine","year":"2016","journal-title":"Science"},{"issue":"1","key":"2026101610065332700_cit21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41467-017-01549-6","article-title":"Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding","volume":"8","author":"Kulp","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"2026101610065332700_cit22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nbt0697-553","article-title":"Yeast surface display for screening combinatorial polypeptide libraries","volume":"15","author":"Boder","year":"1997","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"2026101610065332700_cit23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/19420862.2018.1468952","article-title":"Fab is the most efficient format to express functional antibodies by yeast surface display","volume":"10","author":"Sivelle","year":"2018","journal-title":"mAbs"},{"issue":"8","key":"2026101610065332700_cit24","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1021\/acssynbio.0c00159","article-title":"Multiplex Evolution of Antibody Fragments Utilizing a Yeast Surface Display Platform","volume":"9","author":"Oh","year":"2020","journal-title":"ACS Synth. Biol."},{"issue":"6508","key":"2026101610065332700_cit25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"issue":"11","key":"2026101610065332700_cit26","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.4049\/jimmunol.1800343","article-title":"Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning","volume":"200","author":"Heredia","year":"2018","journal-title":"J. Immunol."},{"issue":"10","key":"2026101610065332700_cit27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109196","article-title":"A mammalian cell based FACS-panning platform for the selection of HIV-1 envelopes for vaccine development","volume":"9","author":"Bruun","year":"2014","journal-title":"PLoS One"},{"issue":"52","key":"2026101610065332700_cit28","doi-asserted-by":"publisher","first-page":"18436","DOI":"10.1074\/jbc.RA120.015053","article-title":"Development of a novel mammalian display system for selection of antibodies against membrane proteins","volume":"295","author":"Robertson","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026101610065332700_cit29","doi-asserted-by":"publisher","first-page":"102109","DOI":"10.1016\/j.xpro.2023.102109","article-title":"Optimized lentiviral vector transduction of adherent cells and analysis in sulforhodamine B proliferation and chromatin immunoprecipitation assays","volume":"4","author":"Li","year":"2023","journal-title":"STAR Protoc."},{"issue":"1","key":"2026101610065332700_cit30","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41467-023-37786-1","article-title":"High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike","volume":"14","author":"Tan","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"2026101610065332700_cit31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3978\/j.issn.2218-6751.2016.01.05","article-title":"PiggyBac transposon vectors: the tools of the human gene encoding","volume":"5","author":"Zhao","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"issue":"10","key":"2026101610065332700_cit32","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.3390\/ijms22105084","article-title":"Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering","volume":"22","author":"Sandoval-Villegas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"2026101610065332700_cit33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/19420862.2016.1160990","article-title":"Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries","volume":"8","author":"Waldmeier","year":"2016","journal-title":"mAbs"},{"issue":"3","key":"2026101610065332700_cit34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/abt\/tbad009","article-title":"A mammalian cell display platform based on scFab transposition","volume":"6","author":"Chang","year":"2023","journal-title":"Antibody Ther."},{"issue":"5","key":"2026101610065332700_cit35","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"issue":"5","key":"2026101610065332700_cit36","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"2026101610065332700_cit37","unstructured":"System Biosciences\n          \n          PiggyBac Transposon Vector System User Manual, 2018."},{"issue":"34","key":"2026101610065332700_cit38","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau2710","article-title":"Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine","volume":"4","author":"Matsuda","year":"2019","journal-title":"Sci. Immunol."},{"key":"2026101610065332700_cit39","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/ncomms4614","article-title":"Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"issue":"5138","key":"2026101610065332700_cit40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1126\/science.8248779","article-title":"A switch between two-three-and four-stranded coiled coils in GCN4 leucine zipper mutants","volume":"262","author":"Harbury","year":"1993","journal-title":"Science"},{"issue":"4","key":"2026101610065332700_cit41","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1073\/pnas.1008322108","article-title":"A hyperactive piggyBac transposase for mammalian applications","volume":"108","author":"Yusa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101610065332700_cit42","doi-asserted-by":"publisher","first-page":"11.04.686334","DOI":"10.1101\/2025.11.04.686334","article-title":"Iterative Immunogen Optimization to Focus Immune Responses on a Conserved, Subdominant Influenza Hemagglutinin Epitope","author":"Marston","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"2026101610065332700_cit43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011401","article-title":"Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens","volume":"19","author":"Swanson","year":"2023","journal-title":"PLoS Pathog."},{"issue":"780","key":"2026101610065332700_cit44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr2218","article-title":"An engineered immunogen activates diverse HIVbroadly neutralizing antibody precursors and promotesacquisition of improbable mutation","volume":"17","author":"Swanson","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"24","key":"2026101610065332700_cit45","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1016\/j.molcel.2021.11.024","article-title":"Rapid characterization of spike variants via mammalian cell surface display","volume":"81","author":"Javanmardi","year":"2021","journal-title":"Mol. Cell"},{"issue":"6496","key":"2026101610065332700_cit46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"issue":"16","key":"2026101610065332700_cit47","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"issue":"1","key":"2026101610065332700_cit48","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."},{"issue":"6559","key":"2026101610065332700_cit49","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix-specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"2026101610065332700_cit50","doi-asserted-by":"publisher","first-page":"105686","DOI":"10.1016\/j.pep.2020.105686","article-title":"Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays","volume":"174","author":"Esposito","year":"2020","journal-title":"Protein Expr Purif"},{"issue":"35","key":"2026101610065332700_cit51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2110105119","article-title":"SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern","volume":"119","author":"Lu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2026101610065332700_cit52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.immuni.2016.03.006","article-title":"Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor","volume":"44","author":"Kong","year":"2016","journal-title":"Immunity"},{"issue":"25","key":"2026101610065332700_cit53","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.1073\/pnas.1004600107","article-title":"Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1","volume":"107","author":"Pejchal","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2026101610065332700_cit54","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.immuni.2022.09.001","article-title":"Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors","volume":"55","author":"Willis","year":"2022","journal-title":"Immunity"},{"issue":"5","key":"2026101610065332700_cit55","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00253-012-4243-5","article-title":"Construction and development of a mammalian cell-based full-length antibody display library for targeting hepatocellular carcinoma","volume":"96","author":"Li","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"2026101610065332700_cit56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-1-59745-554-1_18","article-title":"Mammalian cell display for antibody engineering","volume":"525","author":"Ho","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"9","key":"2026101610065332700_cit57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003181","article-title":"Lentivirus display: stable expression of human antibodies on the surface of human cells and virus particles","volume":"3","author":"Taube","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"2026101610065332700_cit58","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/gt.2011.206","article-title":"Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells","volume":"19","author":"Goyvaerts","year":"2012","journal-title":"Gene Ther."},{"issue":"6","key":"2026101610065332700_cit59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2174\/156652309790031120","article-title":"State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations","volume":"9","author":"Pauwels","year":"2009","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"2026101610065332700_cit60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.mt.6300028","article-title":"transposon-mediated gene transfer in human cells","volume":"15","author":"Wilson","year":"2007","journal-title":"Mol. Ther."},{"issue":"11","key":"2026101610065332700_cit61","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1096\/fj.12-223586","article-title":"A versatile, highly efficient, and potentially safer transposon system for mammalian genome manipulations","volume":"27","author":"Meir","year":"2013","journal-title":"FASEB J."},{"issue":"9","key":"2026101610065332700_cit62","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1134\/S000368381709006x","article-title":"The Transposon as a Tool in Genetic Engineering","volume":"53","author":"Laptev","year":"2017","journal-title":"Appl. Biochem. Microbiol."},{"issue":"2","key":"2026101610065332700_cit63","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display","volume":"1","author":"Chao","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["ACS Synthetic Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acssynbio.6c00027","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/asbcd6\/article-pdf\/doi\/10.1021\/acssynbio.6c00027\/68765236\/sb6c00027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/asbcd6\/article-pdf\/doi\/10.1021\/acssynbio.6c00027\/68765236\/sb6c00027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:23:16Z","timestamp":1792160596000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/asbcd6\/article\/15\/10\/3993\/5445723\/A-Mammalian-Surface-Display-Platform-to-Optimize"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1021\/acssynbio.6c00027","relation":{},"ISSN":["2161-5063"],"issn-type":[{"value":"2161-5063","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}